Cefixime Trihydrate 200 mg + Sulbactam 150 mg Tablet

Cefixime Trihydrate 200 mg + Sulbactam 150 mg Tablet is a tablet formulated with Cefixime Trihydrate 200 mg + Sulbactam 150 mg. The active ingredient profile is Cefixime Trihydrate; Sulbactam, placing the product in the cephalosporin + beta-lactamase inhibitor combination category. Cefixime is a cephalosporin antibiotic, while Sulbactam is a beta-lactamase inhibitor intended to inhibit certain bacterial resistance enzymes. It is supplied as an oral solid-dosage formulation; administration details should follow the approved product literature. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad-spectrum claims. Clinical selection should depend on diagnosis, susceptibility or symptom profile, patient-specific factors and the prescriber's judgement. Prescription status, contraindications, precautions, interactions, adverse effects and dosing must be checked against the current approved label before publication. Manufacturer, licence, storage, shelf-life and market-specific regulatory details should be added only from verified product documentation.